{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T14:44:14Z","timestamp":1781361854342,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.autrev.2021.102990","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T01:23:40Z","timestamp":1635902620000},"page":"102990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction"],"prefix":"10.1016","volume":"21","author":[{"given":"Lavinia Agra","family":"Coletto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gerosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariaconsuelo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Beatrice","family":"Chighizola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.autrev.2021.102990_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.autrev.2021.102990_bb0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/BOR.0000000000000200","article-title":"Update on the pathogenesis and treatment of the antiphospholipid syndrome","volume":"27","author":"Chighizola","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102990_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.02.003","article-title":"The treatment of anti-phospholipid syndrome: a comprehensive clinical approach","volume":"90","author":"Chighizola","year":"2018","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2021.102990_bb0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.autrev.2015.01.002","article-title":"The relevance of \u201cnon-criteria\u201d clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features","volume":"14","author":"Abreu","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2021.102990_bb0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1055\/s-0039-1692702","article-title":"Cardiac manifestations of antiphospholipid syndrome: clinical presentation, role of cardiac imaging, and treatment strategies","volume":"45","author":"Tufano","year":"2019","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.autrev.2021.102990_bb0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.autrev.2014.11.003","article-title":"Antiphospholipid syndrome and the heart: a case series and literature review","volume":"14","author":"Denas","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2021.102990_bb0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/096120339600500306","article-title":"Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves","volume":"5","author":"Ziporen","year":"1996","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.autrev.2021.102990_bb0040","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1191\/096120399678840873","article-title":"Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome","volume":"8","author":"Afek","year":"1999","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/096120339600500111","article-title":"Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings","volume":"5","author":"Garc\u00eda-Torres","year":"1996","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/096120339100100108","article-title":"High prevalence of significant heart valve lesions in patients with the \u201cprimary\u201d antiphospholipid syndrome","volume":"1","author":"Cervera","year":"1991","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.autrev.2021.102990_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-116-4-293","article-title":"Valvular heart disease in the primary antiphospholipid syndrome","volume":"116","author":"Galve","year":"1992","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.autrev.2021.102990_bb0060","first-page":"115","article-title":"The heart in the primary antiphospholipid syndrome","volume":"26","author":"Badui","year":"1995","journal-title":"Arch Med Res"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","article-title":"Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients","volume":"96","author":"Vianna","year":"1994","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0049-0172(97)80034-0","article-title":"Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment","volume":"27","author":"Nesher","year":"1997","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2021.102990_bb0075","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0002-8703(99)70424-2","article-title":"Echocardiographic evaluation of patients with primary antiphospholipid syndrome","volume":"137","author":"Esp\u00ednola-Zavaleta","year":"1999","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.autrev.2021.102990_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.0742-2822.2005.04021.x","article-title":"Valve morphology in antiphospholipid antibody syndrome: echocardiographic features","volume":"22","author":"Qaddoura","year":"2005","journal-title":"Echocardiography"},{"issue":"12","key":"10.1016\/j.autrev.2021.102990_bb0085","first-page":"2402","article-title":"Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study","volume":"31","author":"Zavaleta","year":"2004","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2021.102990_bb0090","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.amjcard.2005.04.022","article-title":"Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome","volume":"96","author":"Turiel","year":"2005","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.autrev.2021.102990_bb0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1191\/096120300678828532","article-title":"Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography","volume":"9","author":"Turiel","year":"2000","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.autrev.2021.102990_bb0100","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.echo.2009.06.023","article-title":"The cardiac manifestations of antiphospholipid syndrome and their echocardiographic recognition","volume":"22","author":"Silbiger","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"10.1016\/j.autrev.2021.102990_bb0105","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2021.102990_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.61.3.195","article-title":"The lung in the antiphospholipid syndrome","volume":"61","author":"Espinosa","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2021.102990_bb0115","first-page":"452","article-title":"The lung in the spectrum of antiphospholipid syndrome","volume":"31","author":"Kanakis","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2021.102990_bb0120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0039-1683994","article-title":"Lung disease in antiphospholipid syndrome","volume":"40","author":"Maioli","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.autrev.2021.102990_bb0125","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11739-018-02021-z","article-title":"Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis","volume":"14","author":"Cheng","year":"2019","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0130","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11926-014-0478-8","article-title":"Pulmonary hypertension in antiphospholipid syndrome","volume":"17","author":"Zuily","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.autrev.2021.102990_bb0135","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/1529-0131(199805)41:5<800::AID-ART5>3.0.CO;2-J","article-title":"Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1","volume":"41","author":"Atsumi","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2021.102990_bb0140","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.STR.0000154858.27353.df","article-title":"Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study","volume":"36","author":"Erdogan","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.autrev.2021.102990_bb0145","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3389\/fimmu.2019.00941","article-title":"Cardiac manifestations of antiphospholipid syndrome with focus on its primary form","volume":"10","author":"Kolitz","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1756-185X.12191","article-title":"Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long-time echocardiography follow-up study","volume":"18","author":"Pardos-Gea","year":"2015","journal-title":"Int J Rheum Dis"},{"issue":"17","key":"10.1016\/j.autrev.2021.102990_bb0155","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","article-title":"Cardiovascular magnetic resonance in myocarditis: a JACC white paper","volume":"53","author":"Friedrich","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.autrev.2021.102990_bb0160","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/CIRCULATIONAHA.113.007417","article-title":"Myocardial catastrophe: a case of sudden, severe myocardial dysfunction","volume":"130","author":"Hucker","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.autrev.2021.102990_bb0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00428-019-02615-8","article-title":"The spectrum of myocarditis: from pathology to the clinics","volume":"475","author":"Leone","year":"2019","journal-title":"Virchows Arch"},{"issue":"12 Pt 1","key":"10.1016\/j.autrev.2021.102990_bb0170","doi-asserted-by":"crossref","first-page":"974","DOI":"10.7326\/0003-4819-116-12-974","article-title":"Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome","volume":"116","author":"Kattwinkel","year":"1992","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.autrev.2021.102990_bb0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.autrev.2021.102990_bb0180","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.autrev.2018.03.011","article-title":"Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: analysis of a cohort of 214 patients","volume":"17","author":"Paule","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2021.102990_bb0185","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.semarthrit.2013.07.016","article-title":"Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and\/or antiphospholipid syndrome: a 10-year follow-up study","volume":"43","author":"Kampolis","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/ard.60.1.43","article-title":"Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome","volume":"60","author":"Tektonidou","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/hrt.62.1.61","article-title":"Findings at necropsy in the heart of a patient with anticardiolipin syndrome","volume":"62","author":"Murphy","year":"1989","journal-title":"Br Heart J"},{"issue":"2","key":"10.1016\/j.autrev.2021.102990_bb0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0167-5273(01)00609-X","article-title":"Myocardial ischaemia with a normal coronary angiogram due to the primary antiphospholipid syndrome","volume":"82","author":"de Vries","year":"2002","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/039463200802100128","article-title":"Dilated cardiomyopathy due to thrombotic microangiopathy as the only manifestation of antiphospholipid syndrome: a case report","volume":"21","author":"Vaccaro","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"10.1016\/j.autrev.2021.102990_bb0210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archinte.1991.00400020129028","article-title":"Occlusive vasculopathy in systemic lupus erythematosus. Association with anticardiolipin antibody","volume":"151","author":"Greisman","year":"1991","journal-title":"Arch Intern Med"},{"issue":"6635","key":"10.1016\/j.autrev.2021.102990_bb0215","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/bmj.296.6635.1505","article-title":"Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus","volume":"296","author":"Brown","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"10.1016\/j.autrev.2021.102990_bb0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1191\/096120301666383277","article-title":"Myocardial microangiopathy associated with antiphospholipid antibodies","volume":"10","author":"Lauwerys","year":"2001","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.autrev.2021.102990_bb0225","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/humrep\/dem179","article-title":"Anticardiolipin antibody levels in women undergoing first in vitro fertilization\/embryo transfer","volume":"22","author":"Caccavo","year":"2007","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.autrev.2021.102990_bb0230","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0002-8703(92)90420-Z","article-title":"Cardiac manifestations of the antiphospholipid syndrome","volume":"124","author":"Kaplan","year":"1992","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.autrev.2021.102990_bb0235","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0046-8177(95)90218-X","article-title":"Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome","volume":"26","author":"Hughson","year":"1995","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2021.102990_bb0240","first-page":"335","article-title":"Clinical presentations and vascular histopathology in autopsied patients with systemic lupus erythematosus and anticardiolipin antibodies","volume":"20","author":"Sipek-Dolnicar","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.102990_bb0245","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaut.2018.07.001","article-title":"Catastrophic antiphospholipid syndrome: lessons from 14 cases successfully treated in a single center. A narrative report","volume":"93","author":"Ruffatti","year":"2018","journal-title":"J Autoimmun"},{"issue":"8","key":"10.1016\/j.autrev.2021.102990_bb0250","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1742-1241.2000.tb10923.x","article-title":"Catastrophic antiphospholipid syndrome presenting as dilated cardiomyopathy with bilateral branch retinal artery thrombosis","volume":"54","author":"Mandal","year":"2000","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0255","doi-asserted-by":"crossref","first-page":"48","DOI":"10.14503\/THIJ-17-6472","article-title":"Catastrophic antiphospholipid syndrome presenting as congestive heart failure in a patient with thrombotic microangiopathy","volume":"46","author":"Tulai","year":"2019","journal-title":"Texas Hear Inst J"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0260","first-page":"44","article-title":"Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: a case series and review","volume":"1","author":"Hermel","year":"2020","journal-title":"J Haem"},{"issue":"2","key":"10.1016\/j.autrev.2021.102990_bb0265","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.autrev.2006.06.007","article-title":"Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors","volume":"6","author":"Bucciarelli","year":"2006","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2021.102990_bb0270","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/heart.84.2.156","article-title":"Images in cardiology. Endomyocardial fibrosis associated with antiphospholipid syndrome","volume":"84","author":"Azeem","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.autrev.2021.102990_bb0275","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3389\/fneur.2018.01001","article-title":"Antiphospholipid syndrome and the neurologist: from pathogenesis to therapy","volume":"9","author":"Fleetwood","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2021.102990_bb0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-319-57613-8_10","article-title":"Cardiac autoimmunity: myocarditis","volume":"1003","author":"Bracamonte-Baran","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"10.1016\/j.autrev.2021.102990_bb0285","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.autrev.2017.05.021","article-title":"Myocarditis in auto-immune or auto-inflammatory diseases","volume":"16","author":"Comarmond","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat Rev Dis Prim"},{"issue":"6","key":"10.1016\/j.autrev.2021.102990_bb0295","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1530\/eje.0.1390641","article-title":"Antiphospholipid syndrome, adrenal failure, dilated cardiomyopathy and chronic hepatitis: an unusual manifestation of multiorgan autoimmune injury?","volume":"139","author":"Tauchmanov\u00e0","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2021.102990_bb0300","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijcard.2018.05.040","article-title":"Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: an echocardiographic study","volume":"271","author":"Tufano","year":"2018","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.autrev.2021.102990_bb0305","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1007\/s10067-018-4088-0","article-title":"Myocardial function in primary antiphospholipid syndrome using speckle-tracking echocardiography","volume":"37","author":"Medina","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2021.102990_bb0310","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/ard.2005.044073","article-title":"Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"66","author":"Paran","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2021.102990_bb0315","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0002-8703(95)90124-8","article-title":"Diastolic dysfunction is a feature of the antiphospholipid syndrome","volume":"129","author":"Hasnie","year":"1995","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.autrev.2021.102990_bb0320","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/hrt.74.5.531","article-title":"M mode and Doppler echocardiographic assessment of left ventricular diastolic function in primary antiphospholipid syndrome","volume":"74","author":"Coudray","year":"1995","journal-title":"Br Heart J"},{"issue":"7","key":"10.1016\/j.autrev.2021.102990_bb0325","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/art.27488","article-title":"Asymptomatic myocardial ischemic disease in antiphospholipid syndrome: a controlled cardiac magnetic resonance imaging study","volume":"62","author":"Sacr\u00e9","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2021.102990_bb0330","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0961203312462265","article-title":"The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis","volume":"22","author":"Mavrogeni","year":"2013","journal-title":"Lupus"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221002706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221002706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:23:36Z","timestamp":1761600216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221002706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1568997221002706"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102990","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102990"}}